23.03.2013 Views

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

On-label Use of Starter<br />

<strong>Orange</strong> <strong>Guide</strong> - Chapter 10: Starters<br />

Q. If a specific dosage of a starter package of a product is not used on-label by a<br />

particular specialty because they never see the appropriate type of patient, but<br />

there is a dosage that can be used on-label by the same specialty, is there any<br />

limitation on what Sales Colleagues can distribute to them?<br />

A. Yes. Sales Colleagues may only distribute starter packages which are<br />

consistent with the on-label use of the product for each particular specialty.<br />

Thus, if a <strong>Pfizer</strong> product has different approved dosages for individual<br />

indications, Sales Colleagues may only distribute those starter dosages that are<br />

indicated for the treatment of conditions that the prescribers they call on are<br />

likely to see among their patient population.<br />

Q. If physicians can prescribe drugs for both on-label <strong>and</strong> off-label uses, can a<br />

Sales Colleague leave starters with a physician who wishes to use them in the<br />

treatment of a patient for an off-label purpose?<br />

A. No. When a Sales Colleague distributes starters, he or she is engaging in<br />

product promotion. Leaving a starter with an HCP implicitly delivers a message<br />

that the product is effective <strong>and</strong> safe for its labeled uses. When an HCP implies<br />

or states that he or she is using a <strong>Pfizer</strong> product for an off-label use, providing<br />

starters to that HCP may be considered off-label promotion <strong>and</strong> may subject<br />

<strong>Pfizer</strong> to prosecution under the False Claims Act. Off-label use can also be<br />

implied if <strong>Pfizer</strong> provides starters to a specialist that does not treat the<br />

condition for which the product is indicated (e.g., Detrol LA to pediatric<br />

urologists, or Viagra to OB/GYNs).<br />

Distribution of Starters to Physicians for Personal Use<br />

Q. If one of a Sales Colleague’s physicians asks her for additional Lyrica starters<br />

because the physician’s spouse suffers from fibromyalgia, can the Colleague<br />

give them to the physician?<br />

A. No. Federal <strong>and</strong> state laws, as well as industry guidelines (the PhRMA Code on<br />

Interactions with Healthcare Professionals <strong>and</strong> the American Medical<br />

Association’s Code of Ethics) prohibit the distribution of starters to HCPs for<br />

their own or their family’s personal use.<br />

186<br />

Rev. 09/12<br />

Page 10 of 17

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!